Background and Objectives We evaluated the outcomes of surgery with or without postoperative radiation therapy (PORT) in the management of medullary thyroid carcinoma (MTC). Methods From two tertiary cancer centers, 297 consecutive patients with MTC treated with PORT (n = 46) between 1990 and 2016 or surgery alone (n = 251) between 2000 and 2016 were reviewed. Results Ten-year cumulative incidences of locoregional and distant failure were 30.2% and 24.9% in the surgery cohort, and 16.9% and 55.2% in the PORT cohort. In the surgery alone cohort, T4 disease, extrathyroidal extension, N1 disease, extranodal extension (ENE), and residual disease after surgery were associated with local failure. The PORT cohort had significantly higher proportio...
Abstract: Study aim: The impact of iterative surgery in medullary thyroid carcinoma is still debated...
BACKGROUND: Surgery is the curative therapy for patients with medullary thyroid carcinoma (MTC). In ...
Background The role of postoperative external beam radiotherapy (EBRT) in patients with residual iod...
Background and Objectives We evaluated the outcomes of surgery with or without postoperative radiati...
Surgery is still the only curative treatment for medullary thyroid cancer (MTC). We evaluated clinic...
BACKGROUND: Surgery is still the only curative treatment for medullary thyroid cancer (MTC). We eval...
AIMS: Evaluation of the impact of the extent of primary surgery and reintervention on the outcome of...
Background. Medullary Thyroid Carcinoma (MTC) originates from the thyroid C cells and accounts for ...
PURPOSE: The objective of this study was to review the clinical outcome and prognosis of patients wi...
Background: We reviewed our experience with medullary thyroid carcinoma (MTC), focusing on recurrenc...
Background: Complete resection is a standard treatment for patients with Masaoka-Koga stages II and ...
Abstract Background Medullary thyroid carcinoma (MTC) accounts for 1-2% of all thyroid cancers. The ...
Objective: Total thyroidectomy can be used as a definitive treatment modality for thyrotoxicosis. Th...
BACKGROUND: Postoperative radiotherapy (PORT) is currently recommended for the treatment of Merkel c...
Abstract: Study aim: The impact of iterative surgery in medullary thyroid carcinoma is still debated...
BACKGROUND: Surgery is the curative therapy for patients with medullary thyroid carcinoma (MTC). In ...
Background The role of postoperative external beam radiotherapy (EBRT) in patients with residual iod...
Background and Objectives We evaluated the outcomes of surgery with or without postoperative radiati...
Surgery is still the only curative treatment for medullary thyroid cancer (MTC). We evaluated clinic...
BACKGROUND: Surgery is still the only curative treatment for medullary thyroid cancer (MTC). We eval...
AIMS: Evaluation of the impact of the extent of primary surgery and reintervention on the outcome of...
Background. Medullary Thyroid Carcinoma (MTC) originates from the thyroid C cells and accounts for ...
PURPOSE: The objective of this study was to review the clinical outcome and prognosis of patients wi...
Background: We reviewed our experience with medullary thyroid carcinoma (MTC), focusing on recurrenc...
Background: Complete resection is a standard treatment for patients with Masaoka-Koga stages II and ...
Abstract Background Medullary thyroid carcinoma (MTC) accounts for 1-2% of all thyroid cancers. The ...
Objective: Total thyroidectomy can be used as a definitive treatment modality for thyrotoxicosis. Th...
BACKGROUND: Postoperative radiotherapy (PORT) is currently recommended for the treatment of Merkel c...
Abstract: Study aim: The impact of iterative surgery in medullary thyroid carcinoma is still debated...
BACKGROUND: Surgery is the curative therapy for patients with medullary thyroid carcinoma (MTC). In ...
Background The role of postoperative external beam radiotherapy (EBRT) in patients with residual iod...